Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Mediwound Ltd

MDWD
Current price
18.08 USD +0.05 USD (+0.28%)
Last closed 17.97 USD
ISIN IL0011316309
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 194 862 832 USD
Yield for 12 month -5.93 %
1Y
3Y
5Y
10Y
15Y
MDWD
21.11.2021 - 28.11.2021

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel. Address: 42 Hayarkon Street, Yavne, Israel, 8122745

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

31.00 USD

P/E ratio

Dividend Yield

Current Year

+20 222 000 USD

Last Year

+18 686 000 USD

Current Quarter

+5 840 000 USD

Last Quarter

+4 355 000 USD

Current Year

+2 634 000 USD

Last Year

+3 578 000 USD

Current Quarter

+903 000 USD

Last Quarter

+677 000 USD

Key Figures MDWD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -18 581 000 USD
Operating Margin TTM -104.47 %
Price to Earnings
Return On Assets TTM -17.33 %
PEG Ratio -0.070
Return On Equity TTM -96.34 %
Wall Street Target Price 31.00 USD
Revenue TTM 20 222 000 USD
Book Value 2.89 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 9.40 %
Dividend Yield
Gross Profit TTM 2 634 000 USD
Earnings per share -3.03 USD
Diluted Eps TTM -3.03 USD
Most Recent Quarter IV 2024
Quarterly Earnings Growth YOY
Profit Margin -149.46 %

Dividend Analytics MDWD

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History MDWD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor 1:7
Payout Ratio TTM
Last Split Date 20.12.2022

Stock Valuation MDWD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 9.51
Price Sales TTM 9.64
Enterprise Value EBITDA -6.32
Price Book MRQ 6.26

Financials MDWD

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators MDWD

For 52 weeks

12.78 USD 24.00 USD
50 Day MA 17.01 USD
Shares Short Prior Month 906 570
200 Day MA 17.70 USD
Short Ratio 11.97
Shares Short 1 005 928
Short Percent 10.43 %